Hereditary angioedema type I patients with anti-C1-INH antibodies can be effectively treated with icatibant

被引：0
|
作者：
Bouillet, L. [1 ]
Boccon-Gibod, I [1 ]
Ponard, D. [1 ]
Dumestre-Perard, C. [2 ]
Cesbron, J. [1 ]
Massot, C. [1 ]
机构：
[1] Grenoble Univ Hosp, Angioedema Natl Reference Ctr, Grenoble, France
[2] CHRU Hop Sud, Immunol Lab, Grenoble, France
来源：
ALLERGY | 2009年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
257
引用
收藏
页码：116 / 117
页数：2
相关论文
共 50 条
  • [21] Longitudinal natural history of patients with type I or II hereditary angioedema: data from the icatibant outcome survey
    Maurer, M.
    Caballero, T.
    Aberer, W.
    Zanichelli, A.
    Bouillet, L.
    Bygum, A.
    Grumach, A. S.
    Pommie, C.
    Andresen, I
    Longhurst, H. J.
    ALLERGY, 2017, 72 : 99 - 99
  • [22] JOINT PAIN: A RARE SYMPTOM IN PATIENTS WITH HEREDITARY ANGIOEDEMA WITH NORMAL C1-INH
    Jones, D.
    Park, N.
    Thompson, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S82 - S82
  • [23] Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema
    Goesswein, T.
    Kocot, A.
    Emmert, G.
    Kreuz, W.
    Martinez-Saguer, I.
    Aygoeren-Puersuen, E.
    Rusicke, E.
    Bork, K.
    Oldenburg, J.
    Mueller, C. R.
    CYTOGENETIC AND GENOME RESEARCH, 2008, 121 (3-4) : 181 - 188
  • [24] Hereditary angioedema: follow up of C1Inh deficiency (Type I-II) patients with long term prophylaxis: (COBRA registry)
    Bouillet, L.
    Boccon-Gibod, I
    Pagnier, A.
    Gompel, A.
    Floccard, B.
    Laurent, J.
    Martin, L.
    Blanchard-Delaunay, C.
    Launay, D.
    Fain, O.
    Du-Than, A.
    Gayet, S.
    Sobel, A.
    Ollivier, Y.
    Jeandel, P-Y
    Pelletier, F.
    ALLERGY, 2016, 71 : 410 - 410
  • [25] Dose justification for recombinant human C1INH for the treatment of acute angioedema attacks in patients with hereditary angioedema
    Relan, A.
    Haase, G.
    Hack, E.
    Nuijens, J.
    Giannetti, B.
    Pijpstra, R.
    ALLERGY, 2010, 65 : 445 - 446
  • [26] The Icatibant Outcome Survey: Observational Data in Patients with Angioedema Due to Acquired C1 Inhibitor (C1-INH) Deficiency
    Longhurst, Hilary
    Zanichelli, Andrea
    Caballero, Teresa
    Bouillet, Laurence
    Aberer, Werner
    Fabien, Vincent
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB279 - AB279
  • [27] Evaluation of a 5-weight-band dosing strategy for icatibant in pediatric patients with hereditary angioedema with C1-inhibitor deficiency type I/II
    Farkas, H.
    Vardi, M.
    Wang, Y.
    ALLERGY, 2018, 73 : 719 - 720
  • [28] Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedema
    Varga, Lilian
    Fuest, George
    Csuka, Dorottya
    Farkas, Henriette
    MOLECULAR IMMUNOLOGY, 2011, 48 (04) : 572 - 576
  • [29] Effects of NO, bradykinin, icatibant or C1-INH on the expression and function of bradykinin type 2 receptors. Role in angioedema?
    Khosravani, F.
    Kojda, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S5 - S5
  • [30] Icatibant effectively alleviates non-laryngeal attacks of hereditary angioedema type I and II irrespective of attack severity or historical attack frequency
    Maurer, M.
    Reshef, A.
    Craig, T.
    Cicardi, M.
    ALLERGY, 2012, 67 : 199 - 200
12345